Osteoporosis in men

Journal of the Royal Society of Medicine

Volumn 94, Issue 12, 2001, Pages 620-623

  Prelevic, G M ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

BONE ATROPHY; BONE DENSITY; BONE METABOLISM; HORMONE SUBSTITUTION; HUMAN; MALE; OSTEOPOROSIS; REVIEW; SEX DIFFERENCE;

EID: 0035217131     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107680109401204     Document Type: Review

References (52)

1. Osteoporosis in men
2. How many women have osteoporosis?
3. Race and sex differences in hip fracture incidence
4. Hip fracture prediction in elderly men and women: Validation in the Rotterdam study
5. Differences in mortality after fracture of hip: The East Anglia audit
6. Hip fracture in elderly men: Prognostic factors and outcomes
7. Mortality after all major types of osteoporotic fracture in men and women: An observational study
8. Gender differences in mortality after hip fracture
9. Determinants of bone mineral density in older men
10. Predictors of bone mass in healthy older men in the community
11. Risk factors for spinal osteoporosis in men
12. Severe osteoporosis in men
13. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: A follow up study
14. Osteopenia in men with a history of delayed puberty
15. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty
16. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty
17. Comment on normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty
18. Osteoporosis in men with idiopathic hypogonadotrophic hypogonadism
19. Corticosteroid induces osteoporosis and hormone implants
20. Bone histomorphometry, bone mass and related parameters in alcoholic males
21. Bone histology in young adult osteoporosis
22. Gender-specific relationships between serum free and total IGF-I and bone mineral density in elderly men and women
23. Insulin-like growth factor-1 in men with idiopathic osteoporosis
24. Osteoporosis in men: A cellular endocrine perspective of an increasingly common clinical problem
25. Testosterone deficiency as a risk factor for hip fractures in men: A case-control study
26. Endogenous sex steroids and bone mineral density in older men and women: The Rancho Bernardo Study
27. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men
28. Osteoporosis after orchiectomy for prostatic cancer
29. Sex steroids and bone mass in older men. Positive association with serum estrogens and negative association with androgens
30. Assessment of sex hormones and bone mineral density in relation to occurrence of fracture in men: A prospective population-based study
31. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
32. A unitary model for involutional osteoporosis:estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
33. Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study
34. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
35. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of oestrogen
36. Osteopenia as a feature of the androgen insensitivity syndrome
37. The contribution of testosterone to skeletal development and maintenance: Lesson from androgen insensitivity syndrome
38. The localisation of androgen receptors in human bone
39. Androgens regulate bone resorption activity in isolated osteoclasts in vitro
40. Androgen effects on bone metabolism: Recent progress and controversies
41. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line
42. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
43. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
44. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism
45. The treatment of isolated hypogonadotropic hypogonadism. Effect on bone mineral density and bone turnover
46. Effects of testosterone treatment on bone mineral density in men over 65 years of age
47. Androgen supplementation in eugonadal men with osteoporosis - Effects of 6 months of treatment on bone mineral density and cardiovascular risk factors
48. Androgen supplementation in eugonadal men with osteoporosis - Effects of 6 months of treatment on markers of bone formation and resorption
49. Alendronate for the treatment of osteoporosis in men
50. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers
51. Histomorphometric, physical and mechanical effects of spaceflight and insulin-like growth factor-1 on rat long bones
52. Osteopenia in rats with liver cirrhosis: Beneficial effects of IGF-1 treatment